首页> 外国专利> Cell culture system for determining the cholesterol efflux potential for serum

Cell culture system for determining the cholesterol efflux potential for serum

机译:用于确定血清胆固醇外流潜能的细胞培养系统

摘要

The present invention relates to a cell culture system to provide a tool for assessing the potential of a patient's serum for preventing the accumulation of cholesterol in arteries (i.e. serum efflux potential) that leads to atherosclerosis and to screen new drug compositions being developed to reduce the accumulation of cholesterol or enhance the clearance of cholesterol from the vessel wall. The present invention combines two individual assays, which are two different cholesterol assays: an assay measuring scavenger receptor class B type I (SR-BI)-mediated cholesterol efflux and an assay measuring ATP binding cassette protein 1 (ABCA1)-mediated cholesterol efflux, and uses them in parallel to test human and animal sera for their potential to stimulate efflux, as mediated by either of the two receptors described above.
机译:本发明涉及一种细胞培养系统,其提供一种工具,该工具用于评估患者的血清预防胆固醇在动脉中积累的潜力(即血清外排潜力),该潜力可导致动脉粥样硬化,并筛选正在开发的药物组合物以减少动脉粥样硬化。胆固醇的积累或提高血管壁中胆固醇的清除率。本发明结合了两种单独的测定法,它们是两种不同的胆固醇测定法:一种测定I型清道夫受体介导的胆固醇流出的测定法和一种测定ATP结合盒蛋白1(ABCA 1 )介导的胆固醇外排,并并行使用它们来测试人和动物血清刺激外排的潜力,这是由上述两种受体之一介导的。

著录项

  • 公开/公告号US2002146681A1

    专利类型

  • 公开/公告日2002-10-10

    原文格式PDF

  • 申请/专利权人 ROTHBLAT GEORGE H.;

    申请/专利号US20020096705

  • 发明设计人 GEORGE H. ROTHBLAT;

    申请日2002-03-13

  • 分类号C12Q1/60;C12Q1/00;

  • 国家 US

  • 入库时间 2022-08-22 00:49:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号